The largest database of trusted experimental protocols

10 protocols using pgl2 vector

1

NF-κB Transcriptional Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
TCam-2 cells (3 × 105 cells per well) were seeded into a 96-well plate a day before transfection. Cells were co-transfected with 80 ng of pGL2 vector (Promega) bearing NF-κB enhancer region and TATA box upstream of firefly luciferase gene,43 (link)Renilla vector (Promega) and shPEG3-1 vector or miR-514a-3p mimic using lipofectamine 2000 (Life Technologies). After 48 h post transfection, firefly and Renilla activity was measured using Dual-Glo Luciferase Assay (E2940; Promega). Firefly luciferase activity was divided by the Renilla luciferase activity in each condition and normalized to the shControl or NC transfectants. All experiments were performed in triplicate independently.
+ Open protocol
+ Expand
2

Investigating YAP/TEAD Binding in NMU Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
The YAP/TEAD binding elements were predicted using the JASPAR database (http://jaspar.genereg.net/). An NMU promoter including the YAP/TEAD binding site was obtained with NMU upstream regions generated by PCR using primers including the KpnI recognition site 5′-CCGGTACCCACCAGACGGACAAAGG-3′ and XhoI recognition site 5′-CCCTCGAGCACCTC TGTGGAAGCAC-3′, and ligated into the pGL2 vector (Promega, Madison, USA) directly. For mutagenesis of the NMU promoter, site-directed mutagenesis was performed following standard protocols as follows: mutation 1, 5′-CATTCATGGTTGGTGGGAATGTAAATTGGTATAAC-3′ to 5′-CATTCATGGTTGGTGGTGGCGTAAATTGGTATAAC-3′, and mutation 2, 5′-ATGTACAAGAACATTCCAAGCAGCCTGGTTCATG-3′ to 5′-ATGTACAAGAACTCGTCAAGCAGCCTGGTTCATG-3′. Successful incorporation of the mutations was confirmed by DNA sequencing. For luciferase assays, 293FT cells were seeded in 24-well plates, and reporter constructs with or without the YAP1 construct and Renilla were co-transfected (Figure 6C). After 24 h, the medium was removed, and the cells were harvested for luciferase assays (Dual Luciferase Assay kit, Promega). Luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Tri-reporter Vector Construction and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tri-reporter was constructed by linking the coding sequences of firefly luciferase, eGFP, and HSV1Δtk, which has a truncation at the HSV1tk N-terminus. As previously described28 (link), the HSV1tk (GenBank: CAA23742) coding sequence (a.a. 1–376) was inserted into the C-terminus of an eGFP expression vector (EGFP-C2, Clontech) at the EcoR1/BamH1 sites. The first 135 bp of HSV1tk in the eGFP-tk vector was removed by PCR-directed mutagenesis, resulting in the eGFP-Δtk vector. The F1B promoter, which was isolated from an F1B-GFP vector12 (link),26 (link) as a 540-bp ApaL1/Age1 fragment, was used to replace the CMV promoter in the eGFP-Δtk vector, resulting in the F1B-eGFP-Δtk vector. The coding sequence of firefly luciferase (Luc) was isolated from the pGL2 vector (Promega) by PCR and inserted into the F1B-eGFP-Δtk vector at the Age1 site to generate the F1B-Luc-eGFP-Δtk vector (F1B-TMIR). Luc was similarly inserted into the eGFP-Δtk vector to generate the CMV-TMIR vector. All vectors were verified by DNA sequencing.
+ Open protocol
+ Expand
4

Tetracycline-Inducible vGPCR Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetracycline-inducible vGPCR construct (TET-vGPCR) was cloned into the TRIPZ vector (Open Biosystems) using AgeI and ClaI restriction sites at the 5’ and 3’ ends, respectively. Tetracycline-inducible control vector (TET-RFP) was purchased from Open Biosystems. Expression constructs: vGPCR was cloned into pcDNA3 vector (Invitrogen, Carlsbad, CA) using EcoRI and XhoI restriction sites; and Rac1QL (constitutively active) and Rac1N17 (dominant negative) were cloned into pcDNA3 using KpnI and XhoI restriction sites. PDGFB-Luc construct was cloned from a 450 bp fragment of the human PDGFB promoter and cloned into pGL2 vector (Promega, Madison, WI) using KpnI and HindIII restriction sites as previously described [57 (link)].
+ Open protocol
+ Expand
5

miR-146a Promoter-Luciferase Construct

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-146a promoter-luciferase gene vector was constructed by ligating the pGL2 vector (Promega) with the miR-146a promoter. Luciferase activity was measured as described previously (16 (link)-18 (link), 20 (link)).
+ Open protocol
+ Expand
6

Cloning and Mutagenesis of Chromatin Modifiers

Check if the same lab product or an alternative is used in the 5 most similar protocols
YY1, SET7/9, G9a, MLL1, SET1A, SET1B, SUV4-20H1, SUV4-20H2, ESET, SUV39H1, SUV39H2, DOT1L, SET8, RIZ1, EZH2 full-length (FL) or truncations were PCR-amplified from cDNA samples prepared from HEK293T cells by using KOD Hot Start DNA Polymerase (Novagen) and then cloned into p3XFLAG-CMV-10 (Sigma), pcDNA3-HA (Invitrogen), pEGFP-C3 (Clontech), pET-28a (+) (Novagen) or pGEX-6P-1 (Promega) expression vectors. All point mutations were generated by using QuikChange Lightning Site-Directed Mutagenesis Kit (Stratagene). Luciferase reporter constructs containing YY1 consensus binding motif (CGCTCCCCGGCCATCTTGGCGGCT GGT) or its mutant form (CGCTCCGCGATTATCTTGGCGGCTGGT) were made in pGL2 vector (Promega).
+ Open protocol
+ Expand
7

Constructing pNA1263 Plasmid for hTERT-Driven Int

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pNA1263 plasmid (Table 1) carrying the int gene of HK022 under the control of hTERT promoter (hTERT) was constructed as follows. A BglII-HindIII hTERT PCR fragment, was generated using primers oEY638 + oEY639 (Table 2) and an hTERT-plasmid as template provided by Dr. S. C. Teng at the Department of Microbiology, National Taiwan University., and this PCR product was ligated into the matching sites of plasmid pNA97938 (link). The pYM1600 plasmid, carrying the luc gene under the control of CMV promoter was constructed by the RF cloning procedure39 (link). The CMV fragment that was obtained by PCR using plasmid pCDNA3 as a template and primers oEY843 + 850 was introduced into the luciferase reporter vector pGL2 vector (Promega, Madison, WI, USA). The pAE1855 plasmid, used as a substrate for the CMV-Luc assays, was constructed by ligation of a AgeI-NotI luc PCR fragment, obtained using pYM1600 as template and primers oEY807 + 808, into the same sites of the intermediate plasmid construct pAE1855inter carrying CMV- attR-Stop-attL cassette on pCDNA3. All plasmid constructs were verified by DNA sequencing.
+ Open protocol
+ Expand
8

Signaling Pathway Activation Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reporter assays were performed as previously reported [9] (link), [42] (link). Briefly, HEK293 cells were transfected with expression plasmids of human PRRs (RIG-I or TLR3 or MDA5), human IFNα4 promoter, or human IFNβ promoter or NFκB-target promoter driven luciferase reporters (pGL2 vector, Promega) and a constitutively transcribed Renilla luciferase reporter (p-RL-TK, Promega) for 24 hr. Cells were then either directly assayed for luciferase activity, or were stimulated with poly (I:C) by either transfecting (500 ng/ml for RIG-I assay) or by adding to the medium (20 µg/ml for TLR3) for additional 18 hr, and luciferase reading was performed using Dual-Glo assay kit (Promega). For ectopic expression assays, HEK293 cells grown overnight were transfected with the indicated plasmids for 24 hr with or without RIG-I and poly (I:C), and luciferase assays were performed. Values were normalized to that of Renilla luciferase internal control.
+ Open protocol
+ Expand
9

Colon cancer stem cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient derived colon CSC-enriched cell lines (CSC_1 and CSC_2) were obtained as previously described (34 (link)).
CSC-LUC, shCD133_1 and shCD133_2 cells were generated by transfecting the cells with the JetPEI® (Polyplus-transfection, Illkirch, France), according to the manufacturer's instructions. The following plasmids were used: PGL2 vector containing the firefly luciferase gene under the control of the SV promoter (Promega Madison, WI, USA), MISSION® CD133 shRNAs TRCN0000424799 and TRCN0000416340 (Sigma-Aldrich, St. Louis, MO, USA).
Cells were grown in ultra-low attachment plates (Corning, Lowell, MA, USA) and maintained in stemness medium (DMEM-F12, Euroclone, Milan, Italy) supplemented as reported in (34 (link)). When indicated, cells were plated under adherent condition in complete medium: DMEM (Euroclone) supplemented with 10% FCS (HyClone, Logan, UT, USA).
RHPS4, synthesized as already reported (35 (link)), was used at 1 μM concentration for different times. ATM-inhibitor KU-55933 (Sigma-Aldrich) was used at 5 μM for 96 h.
+ Open protocol
+ Expand
10

Characterization of Nrf2-Mediated p62 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
SQSTM1/p62 promoter (p62-pro) fragment (from -2046 to +127) with Nrf2 binding site (from -1258 to -1245) was cloned by PCR. Primers used were included in Supplementary Table 2. PCR product was double digested with NheI/HindIII and inserted into pGL2 vector (Promega, Shanghai, China). Cells (1×105) seeded in 12-well plates were co-transfected with Flag-Nrf2 or its mutants, various luciferase reporters and pRL-TK Renilla control luciferase reporter (Promega). Forty-eight hours after transfection, the activities of firefly luciferase and renilla luciferase were measured using the Dual-GloTM luciferase assay system (Promega). Relative luciferase activity was normalized with renilla luciferase activity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!